Show simple item record

dc.contributor.authorGale, Nicola
dc.contributor.authorWasley, David
dc.contributor.authorRoberts, Sioned
dc.contributor.authorBackx, Karianne
dc.contributor.authorNelson, Annemarie
dc.contributor.authorvan Deursen, Robert
dc.contributor.authorByrne, Anthony
dc.date.accessioned2018-08-30T09:54:58Z
dc.date.available2018-08-30T09:54:58Z
dc.date.issued2018-06-02
dc.identifier.citationGale, N., Wasley, D., Roberts, S., Backx, K., Nelson, A., van Deursen, R., Byrne, A. (2018) 'A longitudinal study of muscle strength and function in patients with cancer cachexia', Supportive Care in Cancer. https://doi.org/10.1007/s00520-018-4297-8en_US
dc.identifier.issn0941-4355
dc.identifier.issn1433-7339
dc.identifier.urihttp://hdl.handle.net/10369/9912
dc.descriptionArticle published in Supportive Care in Cancer available at https://doi.org/10.1007/s00520-018-4297-8en_US
dc.description.abstractPurpose Patients with cancer frequently experience an involuntary loss of weight (in particular loss of muscle mass), defined as cachexia, with profound implications for independence and quality of life. The rate at which such patients’ physical performance declines has not been well established. The aim of this study was to determine the change in muscle strength and function over 8 weeks in patients with already established cancer cachexia, to help inform the design and duration of physical activity interventions applicable to this patient group. Methods Patients with thoracic and gastrointestinal cancer, with unintentional weight loss of >5% in 6 months or BMI < 20 plus 2% weight loss were included. Physical and functional assessments (baseline, 4 weeks, 8 weeks) included: isometric quadriceps and hamstring strength, handgrip, standing balance, 10m walk time and timed up and go. Results Fifty patients (32 male), mean ±SD age 65 ±10 years and BMI 24.9 ±4.3kg/m2 were recruited. Thoracic cancer patients had lower muscle strength and function (p<0.05). Despite notable attrition, in patients who completed all assessments (8 thoracic and 12 gastrointestinal) there was little change in performance over 8 weeks (p>0.05). Baseline variables did not differentiate between completers and non-completers (p>0.05). Conclusions More than a third of patients with established cancer cachexia in our study were stable over 8 weeks, suggesting a subgroup who may benefit from targeted interventions of reasonable duration. Better understanding the physical performance parameters which characterize and differentiate these patients has important clinical implications for cancer multidisciplinary team practice.en_US
dc.language.isoenen_US
dc.publisherSpringeren_US
dc.relation.ispartofseriesSupportive Care in Cancer;JSCC-D-17-01100R1
dc.subjectCanceren_US
dc.subjectcachexiaen_US
dc.subjectstrengthen_US
dc.subjectfunctionen_US
dc.titleA longitudinal study of muscle strength and function in patients with cancer cachexiaen_US
dc.typeArticleen_US
dc.identifier.doihttps://doi.org/10.1007/s00520-018-4297-8
dcterms.dateAccepted2018-05-24
rioxxterms.funderCardiff Metropolitan Universityen_US
rioxxterms.identifier.projectCardiff Metropolian (Internal)en_US
rioxxterms.versionAMen_US
rioxxterms.licenseref.urihttp://www.rioxx.net/licenses/under-embargo-all-rights-reserveden_US
rioxxterms.licenseref.startdate2019-06-02
rioxxterms.freetoread.startdate2019-06-02
rioxxterms.funder.project37baf166-7129-4cd4-b6a1-507454d1372een_US


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record